CLINICAL_TRIALS
trial_result
· 2024-02-09
Clinical Trial Update: A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy [Phase 3]
Summary
Phase 3 trial assessing safety and efficacy of levetiracetam (Keppra) in children with epilepsy (partial seizures) has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Pharma | Conditions: Epilepsy, Partial | Phase 3 | Status: COMPLETED | Results posted: 2024-02-09